Bacil Pharma Ltd.

Financial

	Bacil Pharma	Shanmuga Hospital	Vista Pharma
Operational Metrics
Financials
5 yr Average ROE	-73.86 %	55.38 %	-9.45 %
5yr average Equity Multiplier	1.72	1.81	1.52
5yr Average Asset Turnover Ratio	0.0	2.29	0.14
5yr Avg Net Profit Margin	0.0	13.52 %	-199.64 %
Price to Book	2.44	0.0	1.34
P/E	56.45	14.73	0.0
5yr Avg Cash Conversion Cycle	0.0	-0.97 Days	397.29 Days
Inventory Days	0.0	11.41 Days	3019.63 Days
Days Receivable	0.0	54.37 Days	452.93 Days
Days Payable	23.71 Days	38.41 Days	1804.78 Days
5yr Average Interest Coverage Ratio	-950.16	103.51	-2.3
5yr Avg ROCE	-81.01 %	68.42 %	-7.56 %
5yr Avg Operating Profit Margin	0.0	20.12 %	-188.68 %
5 yr average Debt to Equity	0.08	0.39	0.33
5yr CAGR Net Profit	-28.45 %	-4.78 %	4.15 %
5yr Average Return on Assets	-72.13 %	33.09 %	-6.28 %
Shareholdings
Promoter Holding	0.2 %	72.11 %	21.19 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-42.47 %	0.16 %	-14.25 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	-0.02 %

Business

	Bacil Pharma	Shanmuga Hospital	Vista Pharma
Product Wise Break-Up	Product Wise Break-Up Hospital Medicinal Sales 0 Hospital Sales & Services 0 Others 100	Product Wise Break-Up Hospital Sales & Services 70.72 Hospital Medicinal Sales 29.28	Product Wise Break-Up Hospital Sales & Services 0 Hospital Medicinal Sales 0 Others 100